Gut Microbiota-Mediated Transformation of Coptisine Into a Novel Metabolite 8-Oxocoptisine: Insight Into Its Superior Anti-Colitis Effect
Open Access
- 30 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
Abstract
Coptisine (COP) is a bioactive isoquinoline alkaloid derived from Coptis Chinemsis Franch, which is traditionally applied for the management of colitis. However, the blood concentration of COP was extremely low, and its gut microbiota-mediated metabolites were thought to contribute to its prominent bioactivities. To comparatively elucidate the protective effect and underlying mechanism of COP and its novel gut microbiota metabolite (8-oxocoptisine, OCOP) against colitis, we used dextran sulfate sodium (DSS) to induce colitis in mice. Clinical symptoms, microscopic alternation, immune-inflammatory parameters for colitis were estimated. The results indicated that OCOP dramatically ameliorated disease activity index (DAI), the shortening of colon length and colonic histopathological deteriorations. OCOP treatment also suppressed the mRNA expression and release of inflammatory mediators (TGF-β, TNF-α, IL-6, IL-18, IL-1β and IFN-γ) and elevated the transcriptional and translational levels of anti-inflammatory cytokine (IL-10) as well as the mRNA expression levels of adhesion molecules (ICAM-1 and VCAM-1). Besides, the activation of NF-κB pathway and NLRP3 inflammasome was markedly inhibited by OCOP. Furthermore, OCOP displayed superior anti-colitis effect to COP, and was similar to MSZ with much smaller dosage. Taken together, the protective effect of OCOP against DSS-induced colitis might be intimately related to inhibition of NF-κB pathway and NLRP3 inflammasome. And the findings indicated that OCOP might have greater potential than COP to be further exploited as a promising candidate in the treatment of colitis.Keywords
This publication has 63 references indexed in Scilit:
- Effect of salicin on gut inflammation and on selected groups of gut microbiota in dextran sodium sulfate induced mouse model of colitisInflammation Research, 2013
- Styryl-lactone goniothalamin inhibits TNF-α-induced NF-κB activationFood and Chemical Toxicology, 2013
- Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitisJournal of Cellular Physiology, 2011
- Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancerInflammatory Bowel Diseases, 2010
- Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cellsJournal of Experimental Medicine, 2009
- Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced ColitisInflammatory Bowel Diseases, 2009
- Adhesion molecules in chronic ulcerative colitisInternational Journal of Colorectal Disease, 2006
- Gastric-Mucous Membrane Protection Activity of Coptisine Derivatives.Biological and Pharmaceutical Bulletin, 2001
- Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2000
- Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteriaXenobiotica, 1991